Tinnitus and Hearing Center of Arizona - Audiology, Tinnitus, Oticon, Phonak, Resound Hearing Aids Tempe. Formerly Tri-City Audiology Tempe.
TARGETING THE TINNITUS
Research has revealed how the hyperactivity behind tinnitus can be observed in the auditory cortex. The auditory cortex is physically organized according to the pitch of sounds that it perceives, from low to high pitch. The Desyncra™ proprietary pitch-matching procedure makes use of this to target the therapy to the hyperactive region in the auditory cortex. For more information, please visit www.desyncra.com
CHANGED NEURAL BEHAVIOR
Desyncra for Tinnitus applies CR® Neuromodulation to disrupt or “desynchronize” the pathological, neuronal behavior.
Improved symptoms are reflected in EEG imaging, showing reduced delta wave activity across tinnitus neural networks.
Desyncra™ for Tinnitus is a targeted therapy designed to change the patterns in the neuronal networks and reduce the distressing symptoms, including loudness and annoyance.
COMFORT AND CONVENIENCE
The individualized therapy is optimally adjusted to ensure the therapeutic tones are quiet and yet audible. This allows patients to carry on with everyday life while receiving the therapy in the background. Patients have freedom to choose which times of day to do the therapy.
36 WEEK THERAPY
Desyncra for Tinnitus offers therapy over 36 weeks. The therapy starts with an initial fitting appointment, and is followed by further visits at 3, 8, 12, 24 and 36 weeks.
The follow-up visits ensure that the therapeutic tones are continually optimized to the profile of the patient’s tinnitus.
AUDIOLOGY AND NEUROLOGY CONVERGE
Desyncra for Tinnitus applies CR ® Neuromodulation to disrupt the hyperactive, synchronized neuronal behavior behind tinnitus.
Proprietary pitch-matching targets hyperactivity in the auditory cortex
CR® Neuromodulation therapy offers solutions beyond tinnitus to other neurological pathologies, including Parkinson’s disease, epilepsy and migraine.
The mode of delivery is quite different for each of these neurological conditions. Yet in each case, the CR® Neuromodulation is designed to disrupt the synchronized activity and reduce the patient’s symptoms.